Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit - PDF (Russian)
Copyright (c) 2022 Mаrkina U.A., Fomina D.S., Lebedkina M.S., Kruglova T.S., Chernov A.A., Zagrebneva A.I., Mutovina Z.Y., Karaulov A.V., Alexeeva E.I., Lysenko M.A.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.